sweet! -> Dr. David Platt, PhD – Current CEO and Chairman of Oxygen Therapeutics, Inc. https://www.otipharma.com/management-team/ Looks like a nice acquisition target to me. “Dr Platt is a world-renowned expert in carbohydrate chemistry who has founded three publicly traded companies, creating nearly $1B for investors. He has raised $150M directly in public markets in the U.S., and has led development of two drug candidates from concept through phase II clinical trials.”
News 
Market Data 
Discover 
AI
